ATE175676T1 - Propiophenon-derivate und verfahren zur ihrer herstellung - Google Patents
Propiophenon-derivate und verfahren zur ihrer herstellungInfo
- Publication number
- ATE175676T1 ATE175676T1 AT96117088T AT96117088T ATE175676T1 AT E175676 T1 ATE175676 T1 AT E175676T1 AT 96117088 T AT96117088 T AT 96117088T AT 96117088 T AT96117088 T AT 96117088T AT E175676 T1 ATE175676 T1 AT E175676T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- hydrogen atom
- propiophenone derivatives
- propiophenone
- derivatives
- Prior art date
Links
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical class CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 title abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7288487A JP3059088B2 (ja) | 1995-11-07 | 1995-11-07 | プロピオフェノン誘導体およびその製法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE175676T1 true ATE175676T1 (de) | 1999-01-15 |
Family
ID=17730854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96117088T ATE175676T1 (de) | 1995-11-07 | 1996-10-24 | Propiophenon-derivate und verfahren zur ihrer herstellung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5767094A (de) |
| EP (1) | EP0773226B1 (de) |
| JP (1) | JP3059088B2 (de) |
| KR (1) | KR100333572B1 (de) |
| CN (1) | CN1049222C (de) |
| AT (1) | ATE175676T1 (de) |
| CA (1) | CA2189603C (de) |
| DE (1) | DE69601345T2 (de) |
| DK (1) | DK0773226T3 (de) |
| ES (1) | ES2128137T3 (de) |
| SG (1) | SG40895A1 (de) |
| TW (1) | TW460477B (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT850948E (pt) * | 1996-12-26 | 2002-08-30 | Tanabe Seiyaku Co | Derivados propiofenona e processo para a preparacao dos mesmos |
| AU5755200A (en) | 1999-08-27 | 2001-03-26 | Joel R.L. Ehrenkranz | Method of using dihydrochalcone derivatives to block glucose transfer |
| US6515117B2 (en) | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| PH12000002657B1 (en) | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
| US6555519B2 (en) | 2000-03-30 | 2003-04-29 | Bristol-Myers Squibb Company | O-glucosylated benzamide SGLT2 inhibitors and method |
| US6683056B2 (en) | 2000-03-30 | 2004-01-27 | Bristol-Myers Squibb Company | O-aryl glucoside SGLT2 inhibitors and method |
| US6936590B2 (en) | 2001-03-13 | 2005-08-30 | Bristol Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| WO2002080935A1 (en) * | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| JP4590159B2 (ja) * | 2001-04-04 | 2010-12-01 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法 |
| TW200504021A (en) | 2003-01-24 | 2005-02-01 | Bristol Myers Squibb Co | Substituted anilide ligands for the thyroid receptor |
| LT2896397T (lt) | 2003-08-01 | 2017-11-27 | Mitsubishi Tanabe Pharma Corporation | Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį |
| EP1680414A4 (de) * | 2003-08-01 | 2009-05-27 | Janssen Pharmaceutica Nv | Substituierte indazol-o-glukoside |
| AU2004261663A1 (en) * | 2003-08-01 | 2005-02-10 | Janssen Pharmaceutica N.V. | Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides |
| AU2004261660A1 (en) * | 2003-08-01 | 2005-02-10 | Janssen Pharmaceutica N.V. | Substituted fused heterocyclic C-glycosides |
| US8785403B2 (en) | 2003-08-01 | 2014-07-22 | Mitsubishi Tanabe Pharma Corporation | Glucopyranoside compound |
| EP1680131A4 (de) * | 2003-08-01 | 2009-05-27 | Janssen Pharmaceutica Nv | Substituierte indol-o-glucoside |
| FR2862303B1 (fr) * | 2003-11-17 | 2006-01-06 | Agronomique Inst Nat Rech | Preparations colorantes hydrosolubles jaunes derivees des dihydrochalcones, leur procede des preparation, et leurs utilisations |
| TWI332707B (en) | 2005-08-04 | 2010-11-01 | Au Optronics Corp | Array substrate of a liquid crystal display and method of fabricating the same |
| UY30730A1 (es) * | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
| HUE035130T2 (en) * | 2007-09-10 | 2018-05-02 | Janssen Pharmaceutica Nv | A method for preparing compounds useful as SGLT inhibitors |
| CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
| BRPI0913129A2 (pt) | 2008-05-22 | 2016-01-05 | Bristol Myers Squibb Co | método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo |
| US9056850B2 (en) * | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| WO2011003976A1 (en) | 2009-07-10 | 2011-01-13 | Janssen Pharmaceutica Nv | CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL] BENZENE |
| HRP20170446T1 (hr) * | 2009-10-14 | 2017-05-19 | Janssen Pharmaceutica Nv | Postupak pripreme spojeva korisnih kao inhibitori sglt2 |
| AR081036A1 (es) | 2010-05-11 | 2012-05-30 | Janssen Pharmaceutica Nv | Formulaciones farmaceuticas para tratar enfermedades relacionadas con el transportador de glucosa dependiente de sodio |
| KR101913587B1 (ko) | 2011-04-13 | 2018-10-31 | 얀센 파마슈티카 엔.브이. | Sglt2의 억제제로서 유용한 화합물의 제조 방법 |
| TWI542596B (zh) | 2011-05-09 | 2016-07-21 | 健生藥品公司 | （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體 |
| US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
| SG11202100417RA (en) | 2018-07-19 | 2021-02-25 | Astrazeneca Ab | Methods of treating hfpef employing dapagliflozin and compositions comprising the same |
| TW202220672A (zh) | 2020-07-27 | 2022-06-01 | 瑞典商阿斯特捷利康公司 | 用達格列淨治療慢性腎臟病之方法 |
| US20240212818A1 (en) | 2021-04-01 | 2024-06-27 | Astrazeneca Uk Limited | Systems and methods for managing prediabetes with a gliflozin sodiumglucose cotransport 2 inhibitor pharmaceutical composition |
| JP2025503136A (ja) | 2022-01-26 | 2025-01-30 | アストラゼネカ・アクチエボラーグ | 前糖尿病の治療又は２型糖尿病の発症リスクを低減する際に使用するためのダパグリフロジン |
| TW202525278A (zh) | 2023-12-15 | 2025-07-01 | 愛爾蘭商阿斯特捷利康愛爾蘭有限公司 | 治療慢性腎病及高血壓之方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760135A (en) * | 1984-09-06 | 1988-07-26 | University Of Kentucky Research Foundation | Phloretin and phlorizin derivative containing compounds |
| CA2102591C (en) * | 1992-11-12 | 2000-12-26 | Kenji Tsujihara | Hypoglycemic agent |
| US5830873A (en) * | 1994-05-11 | 1998-11-03 | Tanabe Seiyaku Co., Ltd. | Propiophenone derivative and a process for preparing the same |
-
1995
- 1995-11-07 JP JP7288487A patent/JP3059088B2/ja not_active Expired - Lifetime
-
1996
- 1996-10-22 SG SG1996010897A patent/SG40895A1/en unknown
- 1996-10-24 DE DE69601345T patent/DE69601345T2/de not_active Expired - Lifetime
- 1996-10-24 ES ES96117088T patent/ES2128137T3/es not_active Expired - Lifetime
- 1996-10-24 DK DK96117088T patent/DK0773226T3/da active
- 1996-10-24 EP EP96117088A patent/EP0773226B1/de not_active Expired - Lifetime
- 1996-10-24 AT AT96117088T patent/ATE175676T1/de active
- 1996-10-29 TW TW085113180A patent/TW460477B/zh not_active IP Right Cessation
- 1996-11-05 CA CA002189603A patent/CA2189603C/en not_active Expired - Fee Related
- 1996-11-06 KR KR1019960052441A patent/KR100333572B1/ko not_active Expired - Fee Related
- 1996-11-07 CN CN96120521A patent/CN1049222C/zh not_active Expired - Fee Related
- 1996-11-07 US US08/745,048 patent/US5767094A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2189603C (en) | 2003-06-10 |
| JP3059088B2 (ja) | 2000-07-04 |
| KR100333572B1 (ko) | 2002-09-18 |
| MX9605415A (es) | 1997-10-31 |
| CA2189603A1 (en) | 1997-05-08 |
| US5767094A (en) | 1998-06-16 |
| CN1049222C (zh) | 2000-02-09 |
| DE69601345T2 (de) | 1999-06-17 |
| DK0773226T3 (da) | 1999-08-30 |
| KR970027098A (ko) | 1997-06-24 |
| CN1151405A (zh) | 1997-06-11 |
| ES2128137T3 (es) | 1999-05-01 |
| EP0773226A1 (de) | 1997-05-14 |
| DE69601345D1 (de) | 1999-02-25 |
| JPH09124686A (ja) | 1997-05-13 |
| TW460477B (en) | 2001-10-21 |
| EP0773226B1 (de) | 1999-01-13 |
| SG40895A1 (en) | 1997-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE175676T1 (de) | Propiophenon-derivate und verfahren zur ihrer herstellung | |
| CA2183655A1 (en) | 4-polycyclic amino-substituted quinazoline derivatives | |
| HU9600834D0 (en) | Quinazoline derivatives | |
| AU5752194A (en) | Benzimidazole compounds, their use and preparation | |
| ATE178069T1 (de) | Propiophenonderivate und verfahren zu deren herstellung | |
| AU6601294A (en) | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | |
| DE3767672D1 (de) | Chinazolinonderivat und verfahren zu seiner herstellung. | |
| DE69418243D1 (de) | N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung | |
| AU697679B2 (en) | Treatment of tinnitis using neuroprotective agents | |
| ATE207749T1 (de) | Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung von atherosklerose und ischämischer herzerkrankungen | |
| ATE246180T1 (de) | Benzofuranon-derivate und verfahren zu ihrer herstellung | |
| ATE199642T1 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung des knorpelabbaus | |
| AU3797189A (en) | Piperidine derivatives | |
| AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| WO1999004770A3 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
| EP0342587A3 (de) | Thienotriazolodiazepine und ihre pharmazeutische Verwendung | |
| EP1034783A4 (de) | Amidederivaten | |
| HUT50354A (en) | Process for producing new s-adenosylmethionine decarboxilase inhibitors | |
| AU2002214325A1 (en) | Process for producing carbapenem-type antibacterial | |
| AU3309793A (en) | An amphoteric tricyclic compound | |
| DK0855398T3 (da) | Sesquiterpenderivater med antiviral aktivitet | |
| EP0794184A4 (de) | 6-methoxy-1h-benzotriazol-5-carboxamide-derivate, verfahren zur herstellung und diese enthaltende arzneimittel | |
| EP0784973A3 (de) | Quinoxalin-Derivate zur Behandlung von Tinnitus | |
| ATE170400T1 (de) | Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen | |
| DE3767533D1 (de) | D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |